FAS and cancer: CAR-T cells, when activated, can also induce apoptosis of cancer cells negative for the target antigen via the Fas and FasL pathway, thanks to which CAR-T cells can perform effector functions in a cancer tumor, showing the heterogeneous expression of antigens [37].